Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer.
Tchou J, Gottipati S, Goldbach M, Baxter M, Venters S, Balassanian R, Vohra P, Gonzalves D, Ahmad Z, Nayak A, Boughey JC, Mukhtar RA, Chen YY.
Tchou J, et al. Among authors: gottipati s.
Ann Surg Oncol. 2024 Nov;31(12):8093-8101. doi: 10.1245/s10434-024-15889-3. Epub 2024 Aug 8.
Ann Surg Oncol. 2024.
PMID: 39117925
Free PMC article.